axogen

📍 Alachua, United States🗓 Founded 2002👥 394 employees💰 Last funded Jan 2021
Biotechnology Research🌐 axogeninc.com
Website LinkedIn
Axogen is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or discontinuity to peripheral nerves by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain. Axogen’s comprehensive portfolio of products focuses on helping patients touch, run, feel, kiss, smile and hug—some of the many things healthy peripheral nerves allow us to do.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2002
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in axogen?
axogen has 1 investors on record on gritt.io.
When did axogen last raise funding?
The most recent investment in axogen recorded on gritt.io was in January 2021.
When was axogen founded?
axogen was founded in 2002.
What industry is axogen in?
axogen operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is axogen based?
axogen is headquartered in Alachua, United States.